Electromed Inc(ELMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 6 at 4:00 PM ET (Korea 11/7 06:00)
Full metrics table
| Index | RUT | P/E | 20.89 | EPS (ttm) | 1.3 | Insider Own | 17.21% | Shs Outstand | 8.4M | Perf Week | 0.48% |
| Market Cap | 0.23B | Forward P/E | 16.08 | EPS next Y | 16.15% | Insider Trans | -4.13% | Shs Float | 6.9M | Perf Month | -2.27% |
| Enterprise Value | 0.20B | PEG | 0.94 | EPS next Q | 0.26 | Inst Own | 60.82% | Short Float | 2.83% | Perf Quarter | -36.19% |
| Income | 0.01B | P/S | 3.05 | EPS this Y | 11.92% | Inst Trans | 0.37% | Short Ratio | 2.35 | Perf Half Y | 0.89% |
| Sales | 0.07B | P/B | 4.21 | EPS next 5Y | 17.15% | ROA | 18.53% | Short Interest | 0.19M | Perf YTD | -6.7% |
| Book/sh | 6.45 | P/C | 11.01 | EPS past 3/5Y | 52.9% 37.46% | ROE | 23.26% | 52W High | -42.68% ($47.40) | Perf Year | 11.63% |
| Cash/sh | 2.47 | P/FCF | 26.77 | Sales past 3/5Y | 15.35% 15.59% | ROIC | 20.91% | 52W Low | 18.08% ($23.01) | Perf 3Y | 161.25% |
| Dividend Est. | - | EV/EBITDA | 13.69 | EPS Y/Y TTM | 53.24% | Gross Margin | 78.54% | Volatility(W/M) | 4.12% 3.21% | Perf 5Y | 142.16% |
| Dividend TTM | - | EV/Sales | 2.78 | Sales Y/Y TTM | 15.28% | Oper. Margin | 18.82% | ATR (14) | 1 | Perf 10Y | 605.71% |
| Dividend Ex-Date | - | Quick Ratio | 4.39 | EPS Q/Q | 54.03% | Profit Margin | 15.32% | RSI (14) | 46.51 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.69 | Sales Q/Q | 11.64% | SMA20 | -0.26% ($27.24) | Beta | 0.44 | Target Price | $48.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/11/10 | SMA50 | -1.06% ($27.46) | Rel Volume | 0.49 | Prev Close | $26.77 |
| Employees | 197 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 23.14% 0.43% | SMA200 | -13.1% ($31.27) | Avg Volume(3M) | 0.08M | Price | $27.17 |
| IPO | 2010/8/13 | Option/Short | Yes/Yes | Trades | 901 | Volume | 40,960 | Change | 1.49% |
🫁 Electromed (ELMD) is a U.S. medical device company that develops, manufactures, and sells airway clearance therapy devices using high-frequency chest wall oscillation (HFCWO) technology. Its flagship product, the SmartVest System, is a non-invasive therapy device designed to help patients with chronic respiratory conditions, such as bronchiectasis, clear mucus at home. The company considers its direct-to-patient sales model a key competitive strength.
Over the past 1 year, on the lower side
43% below its 1-year high.
Traded less than usual. That is 49% of its average volume.
Next earnings report: November 10
3 days to go.
ELMD makes money exceptionally well
Of every $100 in sales, $18.82 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.9% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,608. Peers typically go for $1,907. Compared with its own 5-year average, it is 35% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +142.2%. The S&P 500 did +57% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 60.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
ROSC Hartford Multifactor Small Cap ETF <0.01% 
DWAS Invesco Dorsey Wright SmallCap Momentum ETF <0.01% 
SQLV Royce Quant Small-Cap Quality Value ETF <0.01% 
FSEG Fidelity Enhanced Small Cap Growth ETF <0.01% 
SMLV State Street SPDR US Small Cap Low Volatility Index ETF <0.01% It ranks #74 of 140 in the industry
Based on market cap of $225M.
FAQ
What kind of company is ELMD?
ELMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ELMD?
The market cap of ELMD is approximately $225M, ranking 3,922 within its sector.
What is the P/E ratio of ELMD?
ELMD has a P/E ratio of approximately 20.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ELMD?
ELMD has recorded a 52-week high of $47.40 and a low of $23.01.
